Using Molecular Cooperativity to Revolutionize Cancer Diagnosis & Treatment
OncoNano Medicine has been hard at work the past few years, preparing a pipeline of technology and therapies that rival many other well-established pharmaceutical operations. Though this has not always been the case, as Dr. Tian Zhao, VP of Research and Development explains.
Tian is not only OncoNano's first employee, but he is also one of the inventors of the technologies that OncoNano Medicine is built upon. Founded in 2014, with an initial CPRIT grant totaling somewhere around $6M, OncoNano Medicine was born in a lab at UT Southwestern and was focused largely on developing its technology to image solid tumors during surgery.